A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies

NCT02564094 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Epoetin beta

Sponsor

Hoffmann-La Roche